The Relationship Between Telephone-Administered Cognitive-Behavioral Therapy for Depression and Neuropsychological Functioning in Parkinson’s Disease

Dobkin, Roseanne D.

doi:10.1176/appi.neuropsych.13030065

Cited by 7 publications

(6 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A number of observational studies have reported CBT to be useful for improving low mood in PD. These included uncontrolled pre‐test–post‐test designs (Berardelli, Pasquini, Bloise, et al, 2015; Dobkin, 2014; Dobkin, Allen, & Menza, 2007; Dobkin, Interian, Durland, Gara, & Menza, 2018; Dobkin, Menza, Allen, Tiu, et al, 2011; Shinmei et al, 2016), case series (Cole & Vaughan, 2005; Dobkin, Allen, & Menza, 2006; Feeney et al, 2005), and a single case study (Richardson & Marshall, 2012). Some of the improvements in mood were also maintained at 1‐month (Dobkin et al, 2006; Feeney et al, 2005) and 3‐month (Shinmei et al, 2016) follow‐ups.…”

Section: Resultsmentioning

confidence: 99%

Psychological interventions for people with Parkinson’s disease in the early 2020s: Where do we stand?

et al. 2020

View full text Add to dashboard Cite

Purpose To explore the heterogeneity of the literature on psychological interventions for psychological difficulties in people with Parkinson’s disease (PD). Methods A scoping review was performed across five major databases (MEDLINE Complete, PsycINFO, CINAHL, Academic Search Ultimate, and Cochrane Library) up to June 2020. Results From an initial return of 4911 citations, 56 studies were included, of which 21 were RCTs. A relatively wide range of therapeutic models have been adopted with people with PD, from common therapies such as cognitive behavioural therapy (CBT) and mindfulness, to less frequent approaches, for example, acceptance and commitment therapy (ACT) and psychodrama. The clinical implications of the findings are discussed, and suggestions are provided for future research on intervention studies and key psychological outcomes. Conclusions CBT appears to be effective in treating depression and sleep disorders in people with PD, while psychoeducation programmes alone should be avoided. The use of CBT to improve anxiety, quality of life, and impulse control, as well mindfulness‐based interventions, should be undertaken with some caution because of insufficient research and inconsistent results. As we enter the new decade, more high‐quality evidence is required for psychological interventions in people with PD in general and to corroborate preliminary positive findings on the adoption of less frequent approaches such as ACT. Practitioner points Parkinson’s disease is a progressive neurodegenerative condition associated with several psychological difficulties which be targeted by psychological interventions. Currently, cognitive behavioural therapy (CBT) can be recommended to treat depression and sleep disorders in people with Parkinson’s, while psychoeducation alone should be avoided. Caution is advised regarding the use of CBT and mindfulness‐based interventions to improve anxiety, quality of life, and impulse control. Further evidence is required for less common approaches, such as acceptance and commitment therapy, psychodrama, and EMDR.

show abstract

Section: Resultsmentioning

confidence: 99%

Psychological interventions for people with Parkinson’s disease in the early 2020s: Where do we stand?

et al. 2020

View full text Add to dashboard Cite

show abstract

“…In particular, cognitive–behavioral therapy combined with usual therapy showed better efficacy than traditional treatment alone. In accordance with Dobkin et al [ 72 , 73 , 74 , 75 ], Wuthrich underlined telephone CBT as a valid tool in the treatment of mood disorders, but it did not significantly reduce anxiety [ 74 , 75 , 76 ].…”

Section: Methodsmentioning

confidence: 71%

The Role of Telemedicine in the Treatment of Cognitive and Psychological Disorders in Parkinson’s Disease: An Overview

et al. 2023

View full text Add to dashboard Cite

Background: This literature review evaluates the use and efficacy of telemedicine in cognitive and psychological treatment in Parkinson’s disease. Methods: Studies performed between 2016 and 2021 that fulfilled inclusion criteria were selected from PubMed, Scopus, Cochrane, and Web of Science databases. All articles were evaluated by title, abstract, and text. All studies that examined the cognitive and psychological/psychotherapy treatment of patients with Parkinson’s disease by telemedicine were included. Results: Telehealth improved cognitive status and emotional/behavioral disorders in this population, and had positive effects on the patients’ and caregivers’ quality of life. Conclusions: Our literature review supports the development and efficacy of cognitive and psychological treatment with telemedicine, but the methodology of the study must be reviewed considering its limitations so as to highlight the benefits and risks of treatment via telemedicine.

show abstract

“…Telephone-based CBT was associated with significant improvement in depressive scores at intervention end30 37 and 4-week follow-up30 but there was no beneficial effect on quality of life. A follow-up analysis of the Dobkin39 study showed that baseline verbal and working memory predicted improvement in depression following the 10-week telephone CBT. Internet-based CBT was associated with significant improvement in depressive but not anxiety scores at therapy end 38.…”

Section: Resultsmentioning

confidence: 99%

Cognitive–behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review

Koychev

Okai

2017

Evid Based Mental Health

View full text Add to dashboard Cite

Neuropsychiatric symptoms are common in Parkinson's disease (PD) and have a disproportionate impact on quality of life and carer burden. Pharmacological treatment is the main approach in dealing with these symptoms, but it is limited by variable efficacy and risk of drug interactions. Non-pharmacological approaches using the cognitive-behavioural therapy (CBT) model are viable alternatives and in this review paper we summarise the evidence of CBT for three of the most common psychiatric manifestations of PD: depression and anxiety, impulse-control disorders and insomnia. Most studies modified the usual CBT format to include modules accounting for problems specific to PD: activity scheduling around motoric function, motor symptoms as triggers of anxiety, fear of falling and preparation for disease progression as well as accommodation of materials for suspected executive dysfunction. We found a growing evidence base that CBT (modified to account for PD-specific problems) is effective in the treatment of PD psychiatric symptoms. Where controlled study design was used, moderate effect sizes are reported for the efficacy of CBT for depression, including with distance administration of CBT. The effects were sustained during follow-up which was between 1 and 6 months. In addition, there are some initial data on the effects of CBT on impulse-control disorders and insomnia. The studies were limited by their small and potentially unrepresentative samples and the quality of sample reporting (eg, concomitant antidepressant and dopaminergic therapy use). Additional welldesigned and adequately powered studies are required to determine the utility of CBT in PD. INTRODUCTIONParkinson's disease (PD) is classically defined by a triad of motor symptoms (tremor, rigidity and bradykinesia). It is, however, increasingly conceptualised as a neuropsychiatric disorder 1 in view of the high prevalence of psychiatric features, including depression, impulse control disorders (ICD) and sleep difficulties.2 These non-motor complications are better predictors of disability, distress and rates to institutionalisation than the motor symptoms.3 Of the non-motor complications, mixed depression and anxiety is the most common psychiatric comorbidity, affecting ∼50% of PD patients, significantly more common that rates in the general population.4 Depression and anxiety are the strongest predictors of poorer quality of life, 5 even in the advanced stages of the illness where the motor features have progressed fully.6 ICD are characterised by repetitive, reward-based behaviours, linked to the dopaminergic medication used to treat the motor symptoms. They affect ∼14% of all PD patients 7 and are associated with psychiatric comorbidity and high carer burden.8 Sleep disturbance is another neuropsychiatric symptom that affects up to 60% of all PD patients.9 It is associated with somnolence 10 and impairment in attention and executive function.11 On the basis of their impact on quality of life and outcome, the recognition and treatment of neuropsych...

show abstract

The Relationship Between Telephone-Administered Cognitive-Behavioral Therapy for Depression and Neuropsychological Functioning in Parkinson’s Disease

Cited by 7 publications

References 5 publications

Psychological interventions for people with Parkinson’s disease in the early 2020s: Where do we stand?

Psychological interventions for people with Parkinson’s disease in the early 2020s: Where do we stand?

The Role of Telemedicine in the Treatment of Cognitive and Psychological Disorders in Parkinson’s Disease: An Overview

Cognitive–behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review

Contact Info

Product

Resources

About